NEJM· @NEJM · X·· 2 小时前AI 评分18
AI 导读
一篇新综述总结了治疗方面的进展，包括靶向药物的获批或扩大适应症、抗体偶联药物和免疫治疗带来的结局改善，以及对分子分型日益增长的依赖。 阅读Sara Alsterlind Hurvitz博士撰写的综述文章《乳腺癌全身治疗进展》：https://nej.md/47AOTFX
正文
A new review summarizes advances in therapy, including approval or expanded use of targeted agents, improved outcomes with antibody–drug conjugates and immunotherapy, and growing reliance on molecular profiling.
Read the Review Article “Advances in Systemic Treatment of Breast Cancer” by Sara Alsterlind Hurvitz, MD: https://nej.md/47AOTFX
来源：NEJM · x.com